Profund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-17,304
| Closed | -$311K | – | 1024 |
|
|
2020
Q2 | $311K | Buy |
17,304
+3,085
| +22% | +$55.4K | 0.02% | 580 |
|
|
2020
Q1 | $101K | Sell |
14,219
-5,844
| -29% | -$41.5K | 0.01% | 704 |
|
|
2019
Q4 | $479K | Buy |
20,063
+2,461
| +14% | +$58.8K | 0.02% | 636 |
|
|
2019
Q3 | $472K | Sell |
17,602
-414
| -2% | -$11.1K | 0.02% | 611 |
|
|
2019
Q2 | $489K | Sell |
18,016
-1,685
| -9% | -$45.7K | 0.02% | 638 |
|
|
2019
Q1 | $684K | Buy |
19,701
+14
| +0.1% | +$486 | 0.03% | 494 |
|
|
2018
Q4 | $384K | Sell |
19,687
-4,878
| -20% | -$95.1K | 0.02% | 607 |
|
|
2018
Q3 | $654K | Buy |
24,565
+2,110
| +9% | +$56.2K | 0.02% | 608 |
|
|
2018
Q2 | $848K | Sell |
22,455
-756
| -3% | -$28.6K | 0.03% | 450 |
|
|
2018
Q1 | $758K | Sell |
23,211
-2,239
| -9% | -$73.1K | 0.03% | 557 |
|
|
2017
Q4 | $1.24M | Sell |
25,450
-2,134
| -8% | -$104K | 0.05% | 373 |
|
|
2017
Q3 | $1.49M | Buy |
27,584
+4,510
| +20% | +$244K | 0.06% | 292 |
|
|
2017
Q2 | $1.3M | Sell |
23,074
-1,997
| -8% | -$112K | 0.06% | 304 |
|
|
2017
Q1 | $983K | Sell |
25,071
-2,162
| -8% | -$84.8K | 0.04% | 453 |
|
|
2016
Q4 | $611K | Sell |
27,233
-3,686
| -12% | -$82.7K | 0.03% | 762 |
|
|
2016
Q3 | $702K | Sell |
30,919
-961
| -3% | -$21.8K | 0.03% | 565 |
|
|
2016
Q2 | $752K | Sell |
31,880
-1,185
| -4% | -$28K | 0.04% | 545 |
|
|
2016
Q1 | $675K | Sell |
33,065
-7,449
| -18% | -$152K | 0.04% | 552 |
|
|
2015
Q4 | $2.08M | Buy |
40,514
+2,022
| +5% | +$104K | 0.1% | 152 |
|
|
2015
Q3 | $1.64M | Buy |
+38,492
| New | +$1.64M | 0.09% | 167 |
|